SCPHARMACEUTICALS INC. Retained Earnings
SCPHARMACEUTICALS INC. had Retained Earnings of -$404.26 million as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-08-07
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$404.26M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$386.24M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$366.49M.
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$347.65M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-06-30 | -$404.26M 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$386.24M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$366.49M 10-Q · filed 2025-08-07 |
| 2024-09-30 | -$347.65M 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$312.54M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$295.45M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$281.35M 10-K · filed 2025-03-19 |
| 2023-09-30 | -$267.53M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$251.90M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$237.75M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$226.54M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$217.29M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$207.13M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$197.43M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$189.70M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$182.38M 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$175.83M 10-Q · filed 2021-08-11 |
| 2021-03-31 | -$168.77M 10-Q · filed 2021-05-12 |
| 2020-12-31 | -$161.66M 10-K · filed 2022-03-22 |
| 2020-09-30 | -$153.88M 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$144.84M 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$136.55M 10-Q · filed 2020-05-12 |
| 2019-12-31 | -$129.46M 10-K · filed 2021-03-23 |
| 2019-09-30 | -$118.64M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$112.43M 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$105.18M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$96.46M 10-K · filed 2020-03-24 |
| 2018-09-30 | -$91.36M 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$85.60M 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$75.75M 10-Q · filed 2018-05-07 |
| 2017-12-31 | -$67.02M 10-K · filed 2019-03-21 |